Caxton Associates (UK)’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-259,406
Closed -$5.12M 766
2025
Q4
$5.12M Buy
+259,406
New +$4.66M 0.1% 65
2025
Q3
Sell
-17,132
Closed -$240K 685
2025
Q2
$240K Buy
+17,132
New +$276K 0.01% 598

Other funds holding ALHC

Caxton Associates (UK)'s ALHC Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 259,406 shares — an estimated $5.12M sold.

Caxton Associates (UK) first reported a position in ALHC in Q2 2025 and held it in 2 quarters. The position peaked at $5.12M in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 259,406 Alignment Healthcare shares in Q1 2026, an estimated $5.12M.
  • Caxton Associates (UK) first reported a position in Alignment Healthcare in Q2 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Alignment Healthcare position peaked at $5.12M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.